Literature DB >> 7363934

Systemic activity of orally administered L-dopa in the elderly Parkinson patient.

M A Evans, E J Triggs, G A Broe, N Saines.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7363934     DOI： 10.1007/bf00561903

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  21 in total

1.  Influence of route of administration on physiological availability of levodopa in dogs.

Authors:  S Cotler; A Holazo; H G Boxenbaum; S A Kaplan
Journal:  J Pharm Sci       Date:  1976-06       Impact factor: 3.534

2.  Clinical analyses of factors influencing L-dopa treatment of Parkinson's syndrome.

Authors:  A K Granerus; G Steg; A Svanborg
Journal:  Acta Med Scand       Date:  1972 Jul-Aug

3.  Effects of levodopa therapy in patients with Parkinson's disease: statistical evidence for reduced tolerance to levodopa in the elderly.

Authors:  B Grad; J Wener; G Rosenberg; S W Wener
Journal:  J Am Geriatr Soc       Date:  1974-11       Impact factor: 5.562

4.  Variability of L-dopa absorption in man.

Authors:  D N Wade; P T Mearrick; D J Birkett; J Morris
Journal:  Aust N Z J Med       Date:  1974-04

5.  Levodopa for parkinsonism in elderly and demented patients.

Authors:  G A Broe; F I Caird
Journal:  Med J Aust       Date:  1973-03-31       Impact factor: 7.738

6.  A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients.

Authors:  G Curzon; B D Kantamaneni; J Trigwell
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

7.  L-dopa treatment failure: explanation and correction.

Authors:  L Rivera-Calimlim; C A Dujovne; J P Morgan; L Lasagna; J R Bianchine
Journal:  Br Med J       Date:  1970-10-10

8.  Absorption and metabolism of levodopa.

Authors:  W B Abrams; C B Coutinho; A S Leon; H E Spiegel
Journal:  JAMA       Date:  1971-12-27       Impact factor: 56.272

9.  Plasma DOPA response to levodopa administration in man: effects of a peripheral decarboxylase inhibitor.

Authors:  D L Dunner; H K Brodie; F K Goodwin
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

10.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12
View more
  21 in total

1.  Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.

Authors:  M Contin; R Riva; P Martinelli; F Albani; A Baruzzi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa.

Authors:  D Deleu; G Ebinger; Y Michotte
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Sustained-release of levodopa: single dose study of a new formulation.

Authors:  M Gerlach; W Kuhn; T Müller; P Klotz; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

Review 5.  Newer aspects of drug therapy in the elderly.

Authors:  F I Caird
Journal:  Klin Wochenschr       Date:  1990-06-19

6.  The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.

Authors:  D R Robertson; N D Wood; H Everest; K Monks; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

Review 7.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 8.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

9.  Intestinal absorption of levodopa in man.

Authors:  U Gundert-Remy; R Hildebrandt; A Stiehl; E Weber; G Zürcher; M Da Prada
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Effect of duration of levodopa/decarboxylase inhibitor therapy on the pharmacokinetic handling of levodopa in elderly patients with idiopathic Parkinson's disease.

Authors:  S G Bowes; C J O'Neill; P W Nicholson; A L Leeman; A A Deshmukh; R J Dobbs; S M Dobbs
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.